ERLOTINIB TREATMENT IN A PATIENT WITH BRAIN METASTASES BY NSCLC

被引：0
|
作者：
Montrone, M. [1 ]
Perrucci, B. [1 ]
Lotesoriere, C. [1 ]
Bruno, M. [1 ]
Fanelli, F. [1 ]
Pisconti, S. [1 ]
机构：
[1] SG Moscati Hosp, Taranto, Italy
来源：
CANCER TREATMENT REVIEWS | 2010年 / 36卷
关键词：
D O I：
10.1016/S0305-7372(10)70079-7
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
53
引用
收藏
页码：S110 / S111
页数：2
相关论文
共 50 条
  • [1] Complete response to erlotinib treatment in brain metastases from recurrent NSCLC
    Lai, CSL
    Boshoff, C
    Falzon, M
    Lee, SM
    THORAX, 2006, 61 (01) : 91 - 91
  • [2] The treatment of NSCLC brain metastases
    Noel-Savina, E.
    Descourt, R.
    Le Fur, E.
    Robinet, G.
    ONCOLOGIE, 2012, 14 (05) : 305 - 309
  • [3] Chemotherapy in the treatment of NSCLC and brain metastases.
    Baekke, J
    Sindrup, H
    Olesen, R
    Palshof, T
    Rytter, C
    Hansen, O
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 645S - 645S
  • [4] Targeting Angiogenesis for Treatment of NSCLC Brain Metastases
    Schettino, C.
    Bareschino, M. A.
    Rossi, A.
    Maione, P.
    Sacco, P. C.
    Colantuoni, G.
    Rossi, E.
    Gridelli, C.
    CURRENT CANCER DRUG TARGETS, 2012, 12 (03) : 289 - 299
  • [5] Randomized Trial of Erlotinib Plus Whole-Brain Radiotherapy for NSCLC Patients With Multiple Brain Metastases
    Lee, Siow Ming
    Lewanski, Conrad R.
    Counsell, Nicholas
    Ottensmeier, Christian
    Bates, Andrew
    Patel, Nirali
    Wadsworth, Christina
    Ngai, Yenting
    Hackshaw, Allan
    Faivre-Finn, Corinne
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2014, 106 (07):
  • [6] Brain Metastases in NSCLC - are TKIs Changing the Treatment Strategy?
    Dempke, Wolfram C. M.
    Edvardsen, Klaus
    Lu, Shun
    Reinmuth, Niels
    Reck, Martin
    Inoue, Akira
    ANTICANCER RESEARCH, 2015, 35 (11) : 5797 - 5806
  • [7] Systemic Treatment for Brain Metastases in NSCLC: A New Chapter
    Acker, Fabian
    Althoff, Friederike C.
    Sebastian, Martin
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (06) : 678 - 681
  • [8] Phase 3 Trial of Whole Brain Radiotherapy with Concurrent Erlotinib Versus WBRT Alone for NSCLC with Brain Metastases (ENTER)
    Yang, Z.
    Zhang, Y.
    Li, R.
    Yisikandaer, A.
    Ren, B.
    Sun, J.
    Li, J.
    Chen, L.
    Zhao, R.
    Zhang, J.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S381 - S382
  • [9] Erlotinib or Radiotherapy in the Treatment of Brain Metastasis from EGRF-Mutant NSCLC?
    Cihan, Yasemin Benderli
    TURKISH THORACIC JOURNAL, 2021, 22 (02): : 184 - 185
  • [10] Erlotinib for the treatment of brain metastases in non-small cell lung cancer
    Brower, Jeffrey V.
    Robins, H. Ian
    EXPERT OPINION ON PHARMACOTHERAPY, 2016, 17 (07) : 1013 - 1021
12345